
Michigan’s Medicaid Expansion Improves Oral Health
As the pandemic’s economic effects drive more people to enroll in Medicaid as safety-net health insurance, the program’s dental coverage can improve oral health in

As the pandemic’s economic effects drive more people to enroll in Medicaid as safety-net health insurance, the program’s dental coverage can improve oral health in

Tara L. Aghaloo, DDS, MD, PhD, an oral and maxillofacial surgeon from the UCLA School of Dentistry, was elected president during the Academy of Osseointegration

Editor’s note: Dental Insurance Hub is a series aimed to help dentists and their dental teams overcome dental insurance obstacles so they can focus on
In the fifth and final of our series of articles analysing the key findings from our research and engagement into the effects of COVID-19 on dental care,
Tokuyama Dental has introduced Rebase III hard denture reline material, offering an even better experience for patients and ease of use for clinicians than the
Police responded to a call of a break-in at Barryton, Mich.-based Professional Dental Associates Office March 18. According to investigators, the suspects broke through a
A year on from when the first lockdown was announced we’re asking you to nominate your lockdown heroes. Following a chaotic year, we’re looking to
Chief dental officer Sara Hurley called on dental teams to ‘play their part’ in protecting women in the wake of the death of Sarah Everard.
Did you tune in for the second ever Online Dentistry Show? You can now catch up with all the lectures On Demand. Thousands turned up

Though oral and esophageal carcinomas frequently metastasize to lymph nodes, there are no current therapies specific to treating these particular cancers, according to researchers at
Study of nearly 7,000 elementary school students demonstrates the success of school-based model and its potential to reduce health disparities and save federal dollars A

A novel synthetic cyclic peptide known as AMY-101 reduces inflammation in gingivitis patients, according to Amyndas Pharmaceuticals, which has completed a phase 2 randomized, placebo-controlled